View in EDS PDF Full Text

The Novartis Malaria Initiative

Saved in:
Bibliographic Details
Title: The Novartis Malaria Initiative
Description: The Novartis Malaria Initiative was designed, as a result of a precedent-setting agreement with the World Health Organization in 2001, to provide a breakthrough treatment for malaria-'at no profit'-for public health systems. What had begun as an exemplary act of corporate responsibility had succeeded beyond any expectations. In 2012, for the second year in a row, Novartis had manufactured and distributed over 100 million units of the anti-malarial drug Coartem. But with the significantly increased volumes came increased costs, bringing into question the sustainability of the program. In 2013, Dr. Linus Igwemezie, executive vice president and head of the Novartis Malaria Initiative, reflected on the evolution of the program and the way forward. His goal was to expand access to Coartem in the private sector through a low-margin, high-volume social business model to eventually enable the Malaria Initiative to break even and become financially sustainable. Was this the right strategy?
Authors: Emilie Billaud, Michael Chu, Vincent Dessain
Resource Type: eBook.
Categories: BUSINESS & ECONOMICS / General
Database: eBook Collection (EBSCOhost)
FullText Links:
  – Type: ebook-pdf
Text:
  Availability: 0
Header DbId: nlebk
DbLabel: eBook Collection (EBSCOhost)
An: 2310027
RelevancyScore: 1057
AccessLevel: 6
PubType: eBook
PubTypeId: ebook
PreciseRelevancyScore: 1057.36352539063
IllustrationInfo
ImageInfo – Size: thumb
  Target: https://rps2images.ebscohost.com/rpsweb/othumb?id=NL$2310027$PDF&s=r
– Size: medium
  Target: https://rps2images.ebscohost.com/rpsweb/othumb?id=NL$2310027$PDF&s=d
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Novartis Malaria Initiative
– Name: Abstract
  Label: Description
  Group: Ab
  Data: The Novartis Malaria Initiative was designed, as a result of a precedent-setting agreement with the World Health Organization in 2001, to provide a breakthrough treatment for malaria-'at no profit'-for public health systems. What had begun as an exemplary act of corporate responsibility had succeeded beyond any expectations. In 2012, for the second year in a row, Novartis had manufactured and distributed over 100 million units of the anti-malarial drug Coartem. But with the significantly increased volumes came increased costs, bringing into question the sustainability of the program. In 2013, Dr. Linus Igwemezie, executive vice president and head of the Novartis Malaria Initiative, reflected on the evolution of the program and the way forward. His goal was to expand access to Coartem in the private sector through a low-margin, high-volume social business model to eventually enable the Malaria Initiative to break even and become financially sustainable. Was this the right strategy?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Emilie+Billaud%22">Emilie Billaud</searchLink><br /><searchLink fieldCode="AR" term="%22Michael+Chu%22">Michael Chu</searchLink><br /><searchLink fieldCode="AR" term="%22Vincent+Dessain%22">Vincent Dessain</searchLink>
– Name: TypePub
  Label: Resource Type
  Group: TypPub
  Data: eBook.
– Name: SubjectBISAC
  Label: Categories
  Group: Su
  Data: <searchLink fieldCode="ZK" term="%22BUSINESS+%26+ECONOMICS+%2F+General%22">BUSINESS & ECONOMICS / General</searchLink>
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=nlebk&AN=2310027
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: The Novartis Malaria Initiative
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Emilie Billaud
      – PersonEntity:
          Name:
            NameFull: Michael Chu
      – PersonEntity:
          Name:
            NameFull: Vincent Dessain
      – PersonEntity:
          Name:
            NameFull: Emilie Billaud
      – PersonEntity:
          Name:
            NameFull: Michael Chu
      – PersonEntity:
          Name:
            NameFull: Vincent Dessain
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2014
          Titles:
            – TitleFull: The Novartis Malaria Initiative
              Type: main
ResultId 1